The BIOACT platform enables real-time cytokine profiling in whole blood for point-of-care disease diagnostics.
Live Poll
Should development of point-of-care diagnostics prioritize ease of use in low-resource settings?
October 5, 2026
AI Agents Identified Successful Drug Trial TargetsResearchers utilized autonomous agents to improve trial success by analyzing 55,984 historical clinical records.
October 4, 2026
AAVantgarde Reported Early Retina Therapy DataThe firm shared clinical and preclinical progress on dual-vector gene therapies at the EURETINA congress.
October 4, 2026
AI Diagnostics Scaled to Combat Rising Drug ResistanceAutomated plate analysis systems aim to shorten infection diagnosis times and improve stewardship.
October 3, 2026
Inhibiting p300/CBP Impairs Early Embryonic DevelopmentResearch identifies how blocking specific histone acetyltransferases disrupts genomic stability in mouse embryos.
October 3, 2026
Antengene Will Present New T Cell Engager PlatformThe company will debut preclinical data on its CD2-based costimulatory platform at the 2026 SITC Annual Meeting.
October 2, 2026
Lonza and Asimov Formed Strategic Biotech CollaborationThe partnership integrates AI-driven cell design with contract manufacturing to scale lentiviral vector production.
October 2, 2026
Biologic Treatments Met Sjögren Disease Trial End PointsNew therapies demonstrated clinical efficacy in phase 3 trials, potentially offering the first disease-modifying options.
October 2, 2026
Research Identified mRNA Influence on Protein FoldingA study found that mRNA secondary structure stability affects protein compaction during translation.
October 2, 2026
Marvel Comics Has Launched DNX Crossover EventThe latest story arc explores a future-integrated biological contingency within Magneto’s DNA.
October 2, 2026
Researchers Mapped DNA-Protein Adducts Without ToxinsThe new pDAIP-seq method reveals how cellular enzymes interact with genomic DNA in their natural state.
